COPD research at National Jewish Health is made possible through funding from a wide variety of sources such as the National Institutes of Health, the National Heart, Lung and Blood Institute, Medicare, foundations and industry sponsors.
COPD Scientific Discoveries at National Jewish Health
- Interplay of genes and environment
- Efficacy of pharmacological treatments
- Cellular changes from smoking
- Long-term drug safety
COPD Clinical Research Areas of Interest
- Pharmacological treatments
- Psychosocial aspects of disease management
- Quality of life factors
- Screening tool development
- Environmental factors
- Genetic factors
National Jewish Health has a repository of biological specimens from more than 4,000 COPD patients seen at National Jewish Health. By cross-referencing these samples with our electronic medical record (EMR), we are able to identify highly relevant samples derived from clinical information collected over time, including laboratory testing, symptoms, diagnoses and demographics.